Tekla Capital Management LLC Nu Cana PLC Transaction History

Tekla Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$4.38 - $7.0 $2.02 Million - $3.22 Million	-460,672 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$4.57 - $6.48 $2.11 Million - $2.99 Million	460,672 New	460,672 $2.38 Million
Q1 2019 May 14, 2019	SELL	$10.92 - $18.03 $107,267 - $177,108	-9,823 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$19.0 - $29.84 $279,547 - $439,035	-14,713 Reduced 59.96%	9,823 $187,000
Q1 2018 May 14, 2018	BUY	$10.04 - $28.25 $246,341 - $693,142	24,536 New	24,536 $464,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $68.4M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.